GlassScriptPhysician profile
Ralf Bernhard Lukner
NPI 1053607507
$1,505.63
in general payments reported to CMS, 2019-2025
10 companies · $80.34 in 2025
The $80.34 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2020: $828 · 2021: $72.48 · 2022: $108 · 2024: $44.47 · 2025: $80.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $124.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $793.32 | 2020 | |
| Glaxosmithkline, LLC. | $236.49 | 2019-2020 | |
| Novo Nordisk INC | $166.70 | 2019-2024 | Ozempic, Rybelsus |
| Lilly USA, LLC | $73.14 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $63.22 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $48.57 | 2022-2025 | Farxiga |
| Janssen Pharmaceuticals, INC | $42.19 | 2022 | |
| Pfizer INC. | $35.29 | 2019 | |
| Insmed, INC. | $27.87 | 2025 | Arikayce |
| Xeris Pharmaceuticals, INC. | $18.84 | 2025 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralf Lukner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.